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Abstract:
Background: Epilepsy is one of the most common non-transmissible
diseases in the world Approximately 50 million people in the world sutt,
fi-orn epilepsy. Despite new advances in treatment of epilepsy, patients u i:
epilepsy suffer from uncontrolled and resistant to epilepsy. In addition : 
-
drug therapy, complement therapy can be helpful. Arginine is a precursc:
of nitric oxide and is an essential amino acid. The role of th,.
neurotransmitter has been widely reported in chemical and electric:,
seizures and epilepsy in humans. Therefore, we decided to study the effec.
of L-ARGININE on treatment-resistant epilepsy.
Materials and Methods: Patients with persistant epilepsy who at least ha., 
=
apprppriate two anti-epileptic drug with enough dose Still suffering fro;:
seizures at least one in month have been studied. We randomly divide:
patients into 21 groups. We asked all patients for one month and a period c,
attacks and a feeling of well-being. We gave Arginine supplementation to .
group of patients twice as much-as needed daily, and the other gror:
received a mcdiating drug sirnilar to that of argenin. After three months. ',,. .
again evaluated the patients in terms of previous criteria. At the end. tr..
analysis of their results and their rcports took place.
Results: Twenty-four patients were examined in tlvo groups of 2l patien..
The two groups were compared in terms of quality of life in the pas. -
weeks before and after treatment, which was not statistically significa:..
(Respectively p : 0.588 and P : 0.084). The number of attacks a:..
treatment in the group that consumed arginine was lower than that oi :,--
control group (P : 0.009). Also, in the group treated with arginine. . 
-
number of post-treatment attacks decreased, which was statisi,c.
significant (P:0.014).
Conclusion: The results of this study prove that the potential levels c- ,, 
-
NO signaling system play a role in regulating seizure suscepr;:i ..
Arginine can play a protective role in the brain and reduce the our--r:
seizure attacks.
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